These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27976571)

  • 1. [Fluoroquinolones: Non-antibacterial properties].
    Leyva-Ramos S; Hernández-López H
    Rev Esp Quimioter; 2017 Feb; 30(1):1-8. PubMed ID: 27976571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Trends and Future Directions of Fluoroquinolones.
    Mohammed HHH; Abuo-Rahma GEAA; Abbas SH; Abdelhafez EMN
    Curr Med Chem; 2019; 26(17):3132-3149. PubMed ID: 29446718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards anticancer fluoroquinolones: A review article.
    Abdel-Aal MAA; Abdel-Aziz SA; Shaykoon MSA; Abuo-Rahma GEA
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800376. PubMed ID: 31215674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure, spectroscopic, and biological study of the copper(II) complex with third-generation quinolone antibiotic sparfloxacin.
    Efthimiadou EK; Sanakis Y; Raptopoulou CP; Karaliota A; Katsaros N; Psomas G
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3864-7. PubMed ID: 16697195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?
    Dalhoff A
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):661-8. PubMed ID: 25515946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents.
    Wang Y; Damu GL; Lv JS; Geng RX; Yang DC; Zhou CH
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5363-6. PubMed ID: 22884108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro antimicrobial evaluation of novel fluoroquinolone derivatives.
    Srinivasan S; Beema Shafreen RM; Nithyanand P; Manisankar P; Pandian SK
    Eur J Med Chem; 2010 Dec; 45(12):6101-5. PubMed ID: 20933306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in biological activities of synthesized phenothiazines.
    Pluta K; Morak-Młodawska B; Jeleń M
    Eur J Med Chem; 2011 Aug; 46(8):3179-89. PubMed ID: 21620536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and biological evaluation of novel quinolone-based metronidazole derivatives as potent Cu(2+) mediated DNA-targeting antibacterial agents.
    Zhang L; Kumar KV; Geng RX; Zhou CH
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3699-705. PubMed ID: 26149183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New imidazolidineiminothione derivatives: Synthesis, spectral characterization and evaluation of antitumor, antiviral, antibacterial and antifungal activities.
    Moussa Z; El-Sharief MAMS; Abbas SY
    Eur J Med Chem; 2016 Oct; 122():419-428. PubMed ID: 27393950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral properties of quinolone-based drugs.
    Richter S; Parolin C; Palumbo M; Palù G
    Curr Drug Targets Infect Disord; 2004 Jun; 4(2):111-6. PubMed ID: 15180459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and antibacterial evaluation of decarboxylated fluoroquinolones.
    Nguyen ST; Ding X; Butler MM; Tashjian TF; Peet NP; Bowlin TL
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5961-3. PubMed ID: 21865042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents.
    Al-Trawneh SA; Zahra JA; Kamal MR; El-Abadelah MM; Zani F; Incerti M; Cavazzoni A; Alfieri RR; Petronini PG; Vicini P
    Bioorg Med Chem; 2010 Aug; 18(16):5873-84. PubMed ID: 20667744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent pharmacological advancements in schiff bases: a review.
    Murtaza G; Mumtaz A; Khan FA; Ahmad S; Azhar S; Khan SA; Najam-Ul-Haq M; Atif M; Khan SA; Maalik A; Azhar S; Murtaza G
    Acta Pol Pharm; 2014; 71(4):531-5. PubMed ID: 25272879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, molecular docking, and antibacterial evaluation of some novel flouroquinolone derivatives as potent antibacterial agent.
    Patel MM; Patel LJ
    ScientificWorldJournal; 2014; 2014():897187. PubMed ID: 25574496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recently reported biological activities of pyrazole compounds.
    Faria JV; Vegi PF; Miguita AGC; Dos Santos MS; Boechat N; Bernardino AMR
    Bioorg Med Chem; 2017 Nov; 25(21):5891-5903. PubMed ID: 28988624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study.
    Cheng Y; Qu H; Ma M; Xu Z; Xu P; Fang Y; Xu T
    Eur J Med Chem; 2007 Jul; 42(7):1032-8. PubMed ID: 17336426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal proteinaceous compounds with multiple biological activities.
    Ng TB; Cheung RCF; Wong JH; Chan YS; Dan X; Pan W; Wang H; Guan S; Chan K; Ye X; Liu F; Xia L; Chan WY
    Appl Microbiol Biotechnol; 2016 Aug; 100(15):6601-6617. PubMed ID: 27338574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin.
    Chan PF; Srikannathasan V; Huang J; Cui H; Fosberry AP; Gu M; Hann MM; Hibbs M; Homes P; Ingraham K; Pizzollo J; Shen C; Shillings AJ; Spitzfaden CE; Tanner R; Theobald AJ; Stavenger RA; Bax BD; Gwynn MN
    Nat Commun; 2015 Dec; 6():10048. PubMed ID: 26640131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.